» Articles » PMID: 20105316

Levetiracetam Attenuates Hippocampal Expression of Synaptic Plasticity-related Immediate Early and Late Response Genes in Amygdala-kindled Rats

Overview
Journal BMC Neurosci
Publisher Biomed Central
Specialty Neurology
Date 2010 Jan 29
PMID 20105316
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The amygdala-kindled rat is a model for human temporal lobe epilepsy and activity-dependent synaptic plasticity. Hippocampal RNA isolated from amygdala-kindled rats at different kindling stages was analyzed to identify kindling-induced genes. Furthermore, effects of the anti-epileptic drug levetiracetam on kindling-induced gene expression were examined.

Results: Cyclooxygenase-2 (Cox-2), Protocadherin-8 (Pcdh8) and TGF-beta-inducible early response gene-1 (TIEG1) were identified and verified as differentially expressed transcripts in the hippocampus of kindled rats by in situ hybridization and quantitative RT-PCR. In addition, we identified a panel of 16 additional transcripts which included Arc, Egr3/Pilot, Homer1a, Ania-3, MMP9, Narp, c-fos, NGF, BDNF, NT-3, Synaptopodin, Pim1 kinase, TNF-alpha, RGS2, Egr2/krox-20 and beta-A activin that were differentially expressed in the hippocampus of amygdala-kindled rats. The list consists of many synaptic plasticity-related immediate early genes (IEGs) as well as some late response genes encoding transcription factors, neurotrophic factors and proteins that are known to regulate synaptic remodelling. In the hippocampus, induction of IEG expression was dependent on the afterdischarge (AD) duration. Levetiracetam, 40 mg/kg, suppressed the development of kindling measured as severity of seizures and AD duration. In addition, single animal profiling also showed that levetiracetam attenuated the observed kindling-induced IEG expression; an effect that paralleled the anti-epileptic effect of the drug on AD duration.

Conclusions: The present study provides mRNA expression data that suggest that levetiracetam attenuates expression of genes known to regulate synaptic remodelling. In the kindled rat, levetiracetam does so by shortening the AD duration thereby reducing the seizure-induced changes in mRNA expression in the hippocampus.

Citing Articles

Changes in the Dentate Gyrus Gene Expression Profile Induced by Levetiracetam Treatment in Rats with Mesial Temporal Lobe Epilepsy.

Diaz-Villegas V, Pichardo-Macias L, Juarez-Mendez S, Ignacio-Mejia I, Cardenas-Rodriguez N, Antonio Vargas-Hernandez M Int J Mol Sci. 2024; 25(3).

PMID: 38338984 PMC: 10855401. DOI: 10.3390/ijms25031690.


Brain Neuroplasticity after Treatment with Antiseizure: A Review.

de Souza D, Costa H, Idalina Neta F, de Gois Morais P, de Medeiros Guerra L, Guzen F Clin Psychopharmacol Neurosci. 2023; 21(4):665-675.

PMID: 37859439 PMC: 10591163. DOI: 10.9758/cpn.23.1058.


Excessive/Aberrant and Maladaptive Synaptic Plasticity: A Hypothesis for the Pathogenesis of Alzheimer's Disease.

Kawabata S Front Aging Neurosci. 2022; 14:913693.

PMID: 35865745 PMC: 9294348. DOI: 10.3389/fnagi.2022.913693.


A rat model of a focal mosaic expression of PCDH19 replicates human brain developmental abnormalities and behaviours.

Cwetsch A, Ziogas I, Narducci R, Savardi A, Bolla M, Pinto B Brain Commun. 2022; 4(3):fcac091.

PMID: 35528232 PMC: 9070467. DOI: 10.1093/braincomms/fcac091.


Levetiracetam Mechanisms of Action: From Molecules to Systems.

Contreras-Garcia I, Cardenas-Rodriguez N, Romo-Mancillas A, Bandala C, Zamudio S, Gomez-Manzo S Pharmaceuticals (Basel). 2022; 15(4).

PMID: 35455472 PMC: 9030752. DOI: 10.3390/ph15040475.


References
1.
Heaney D, MacDonald B, Everitt A, Stevenson S, Leonardi G, Wilkinson P . Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ. 2002; 325(7371):1013-6. PMC: 131020. DOI: 10.1136/bmj.325.7371.1013. View

2.
Winer J, Jung C, Shackel I, Williams P . Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999; 270(1):41-9. DOI: 10.1006/abio.1999.4085. View

3.
Scheffer I, Berkovic S . The genetics of human epilepsy. Trends Pharmacol Sci. 2003; 24(8):428-33. DOI: 10.1016/S0165-6147(03)00194-9. View

4.
Loscher W, Honack D . Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol. 1993; 232(2-3):147-58. DOI: 10.1016/0014-2999(93)90768-d. View

5.
Arion D, Sabatini M, Unger T, Pastor J, Alonso-Nanclares L, Ballesteros-Yanez I . Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy. Neurobiol Dis. 2006; 22(2):374-87. DOI: 10.1016/j.nbd.2005.12.012. View